- Home
- KNSA vs LGN Comparison
KNSA vs LGN Comparison
Compare KNSA & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- LGN
- Stock Information
- Founded
- KNSA 2015
- LGN 1963
- Country
- KNSA United Kingdom
- LGN United States
- Employees
- KNSA N/A
- LGN N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- LGN
- Sector
- KNSA Health Care
- LGN
- Exchange
- KNSA Nasdaq
- LGN Nasdaq
- Market Cap
- KNSA 2.6B
- LGN 3.1B
- IPO Year
- KNSA 2018
- LGN 2025
- Fundamental
- Price
- KNSA $38.36
- LGN $35.35
- Analyst Decision
- KNSA Strong Buy
- LGN Strong Buy
- Analyst Count
- KNSA 7
- LGN 12
- Target Price
- KNSA $49.71
- LGN $37.54
- AVG Volume (30 Days)
- KNSA 546.2K
- LGN 824.0K
- Earning Date
- KNSA 10-28-2025
- LGN 11-14-2025
- Dividend Yield
- KNSA N/A
- LGN N/A
- EPS Growth
- KNSA N/A
- LGN N/A
- EPS
- KNSA 0.47
- LGN N/A
- Revenue
- KNSA $597,973,000.00
- LGN $2,213,862,000.00
- Revenue This Year
- KNSA $62.63
- LGN $13.22
- Revenue Next Year
- KNSA $29.93
- LGN $11.87
- P/E Ratio
- KNSA $82.19
- LGN N/A
- Revenue Growth
- KNSA 55.68
- LGN 77.61
- 52 Week Low
- KNSA $17.82
- LGN $26.96
- 52 Week High
- KNSA $42.05
- LGN $43.82
- Technical
- Relative Strength Index (RSI)
- KNSA 52.71
- LGN N/A
- Support Level
- KNSA $36.56
- LGN N/A
- Resistance Level
- KNSA $39.66
- LGN N/A
- Average True Range (ATR)
- KNSA 1.58
- LGN 0.00
- MACD
- KNSA -0.13
- LGN 0.00
- Stochastic Oscillator
- KNSA 50.78
- LGN 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.